Author summary
61%10 analyzed articles/videos2,081 analyzed words
BS Summary: These Ed Silverman results contain 33 faulty reasoning types, including Biased Writer Voice, Negativity Bias, and Appeal to Authority, with Framing Effect as the most egregious example at 22.2% saturation with 1,742 hits. Analysis detected 8,838 faulty-reasoning hits from 7,832 analyzed words across 10 articles, generating a BS Score of 3.4% and a BS Rank of 67% (2,089 of 6,315 authors). This Ed Silverman is worse (more manipulative) than 66.90% of the peer group.
Ed Silverman
Author ranking list
PercentileAuthorBS Score
0%Vivek Chibber1%
0%Sneha Dey1%
0%Ideastream Public Media1%
0%Megan Fan Munce1%
1%Los Angeles Times staff1%
67%Ed Silverman (selected)4%
100%Greg Rosenstein38%
100%Siham Shamalakh43%
100%Greg Miller54%
100%Kevin Kniestedt60%
100%Bill Radke60%
Author details
Total words: 7,832
Article count: 10
Publications

Ranking context

Position among analyzed authors

67% percentile
025507510066.9% percentile
3.4% BS Score10 analyzed articles7.8K analyzed words

Reasoning profile

Selected profile versus the sitewide rate

AuthorSitewideShared scale 0–50%
0.0%10%20%30%40%50%Biased Writer VoiceSitewide 5.3%Author 14.9%14.9%Appeal to EmotionSitewide 15.9%Author 7.0%7.0%Negativity BiasSitewide 19.2%Author 12.5%12.5%In-Group BiasSitewide 6.9%Author 0.4%0.4%Halo EffectSitewide 6.7%Author 1.1%1.1%Availability HeuristicSitewide 9.1%Author 3.4%3.4%Framing EffectSitewide 26.9%Author 22.2%22.2%Appeal to AuthoritySitewide 11.1%Author 7.1%7.1%Quote-first MisdirectionSitewide 0.0%Author 3.5%3.5%Unattributed QuoteSitewide 1.1%Author 4.4%4.4%

Sitewide departure map

Above the diagonal means this profile uses the pattern more often

0.0%0.0%10%10%20%20%30%30%40%40%50%50%Framing Effect: Author 22.2%, sitewide 26.9%Negativity Bias: Author 12.5%, sitewide 19.2%Appeal to Emotion: Author 7.0%, sitewide 15.9%Biased Writer Voice: Author 14.9%, sitewide 5.3%Appeal to Authority: Author 7.1%, sitewide 11.1%Availability Heuristic: Author 3.4%, sitewide 9.1%Hasty Generalization: Author 5.0%, sitewide 8.1%Confirmation Bias: Author 5.5%, sitewide 7.5%In-Group Bias: Author 0.4%, sitewide 6.9%Halo Effect: Author 1.1%, sitewide 6.7%Optimism Bias: Author 5.3%, sitewide 6.0%Unattributed Quote: Author 4.4%, sitewide 1.1%Anchoring Bias: Author 1.6%, sitewide 4.0%Self-Serving Bias: Author 0.6%, sitewide 3.7%Quote-first Misdirection: Author 3.5%, sitewide 0.0%Post Hoc (False Cause): Author 0.3%, sitewide 3.3%Indoctrination: Author 2.8%, sitewide 0.0%Fundamental Attribution Error: Author 0.7%, sitewide 2.7%Recency Bias: Author 1.0%, sitewide 2.7%Loss Aversion: Author 0.6%, sitewide 2.5%Bandwagon: Author 0.3%, sitewide 2.2%Status Quo Bias: Author 1.5%, sitewide 2.2%Ambiguity (Equivocation): Author 2.0%, sitewide 0.8%Politically Left Leaning Bias: Author 0.9%, sitewide 2.0%Framing EffectSitewide rateAuthor rate

Analyzed articles and videos

FDA is urged by advocacy group to ban DTC prescription drug ads59%
STAT42%By Ed Silverman61%7/23/2026, 1:00:00 PM
STAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and more60%
STAT42%By Ed Silverman61%7/21/2026, 1:08:39 PM
STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and more43%
STAT42%By Ed Silverman61%7/15/2026, 1:06:40 PM
FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access81%
STAT42%By Ed Silverman61%7/14/2026, 8:55:49 PM
Sales from controversial U.S. drug discount program rose to $100 billion last year30%
STAT42%By Ed Silverman61%7/14/2026, 7:57:23 PM
AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents59%
STAT42%By Ed Silverman61%7/13/2026, 8:58:46 PM
STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds18%
www.statnews.com42%By Ed Silverman61%7/13/2026, 1:08:34 PM
Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals57%
STAT42%By Ed Silverman61%7/2/2026, 7:52:14 PM
Up and down the ladder: The latest comings and goings40%
STAT42%By Ed Silverman61%7/2/2026, 5:32:09 PM
U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug84%
STAT42%By Ed Silverman61%7/2/2026, 12:54:40 PM